-+ 0.00%
-+ 0.00%
-+ 0.00%

Preview: Arcutis Biotherapeutics's Earnings

Benzinga·02/24/2026 16:02:14
Listen to the news

Arcutis Biotherapeutics (NASDAQ:ARQT) is gearing up to announce its quarterly earnings on Wednesday, 2026-02-25. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Arcutis Biotherapeutics will report an earnings per share (EPS) of $0.07.

The market awaits Arcutis Biotherapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Earnings Track Record

Last quarter the company beat EPS by $0.16, which was followed by a 1.36% increase in the share price the next day.

Here's a look at Arcutis Biotherapeutics's past performance and the resulting price change:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.10 -0.16 -0.21 -0.27
EPS Actual 0.06 -0.13 -0.20 -0.09
Price Change % 1.00 -8.00 -4.00 8.00

eps graph

Arcutis Biotherapeutics Share Price Analysis

Shares of Arcutis Biotherapeutics were trading at $26.31 as of February 23. Over the last 52-week period, shares are up 103.18%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analysts' Take on Arcutis Biotherapeutics

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Arcutis Biotherapeutics.

Analysts have given Arcutis Biotherapeutics a total of ratings, with the consensus rating being . The average one-year price target is $, indicating a potential .

To track all earnings releases for Arcutis Biotherapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.